Alerts will be sent to your verified email
Verify Email
GUJINJEC
|
Guj. Inject (Kerala)
|
ANG Lifesciences
|
Veerhealth Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.55 % | 11.51 % | 2.69 % |
|
5yr average Equity Multiplier
|
0.11 | 3.24 | 1.31 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.88 | 0.54 |
|
5yr Avg Net Profit Margin
|
-175.28 % | 1.44 % | 4.02 % |
|
Price to Book
|
3.7 | 0.56 | 1.67 |
|
P/E
|
36.28 | 0.0 | 93.5 |
|
5yr Avg Cash Conversion Cycle
|
-14.62 Days | 57.8 Days | 80.55 Days |
|
Inventory Days
|
38.61 Days | 76.41 Days | 54.84 Days |
|
Days Receivable
|
0.0 | 195.39 Days | 79.49 Days |
|
Days Payable
|
156.02 Days | 179.71 Days | 58.93 Days |
|
5yr Average Interest Coverage Ratio
|
298.1 | 2.65 | 208.32 |
|
5yr Avg ROCE
|
2.0 % | 22.81 % | 4.25 % |
|
5yr Avg Operating Profit Margin
|
-279.73 % | 10.92 % | 0.98 % |
|
5 yr average Debt to Equity
|
-0.62 | 0.87 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | n/a | 5.08 % |
|
5yr Average Return on Assets
|
-116.01 % | 3.23 % | 2.18 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 70.6 % | 31.5 % |
|
Share Pledged by Promoters
|
0.0 | 44.88 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.54 % | -10.84 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Inject (Kerala)
|
ANG Lifesciences
|
Veerhealth Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|